However, EREG and AREG supplementation of cancer stem cell-enriched tumor spheroids from mCRC patient-derived xenografts did not confer protection from cetuximab treatment, while other EGFR ligands such as EGF and TGFα did [83]. Here, EGFR is linked to neoplasm.